Concert Genetics
Marshall Baughman's work experience can be summarized as follows:
- Software Engineer at Concert Genetics since September 2022.
- Co-Founder of Baughaday Rocketry & Robotics, supporting STEAM education in local schools with donations of 3D printers, robotics kits, and model rocketry sets since March 2021.
- Software Engineer and Support at Allied Boiler & Supply Inc. from December 2019 to September 2022. Responsible for developing a microcontroller-based system, providing software design, testing, customer support, and issue resolution.
- Boiler Technician at Allied Boiler and Supply Inc. since August 2013.
- M.S. Biology student researcher at Middle Tennessee State University (MTSU) from May 2017 to May 2019.
- Infantryman in the US Army from June 2007 to August 2013.
Marshall Baughman has a Master's degree in Biology from Middle Tennessee State University (MTSU). Marshall completed this degree in 2022. Prior to that, they obtained a Bachelor's degree in Biology from the same university, graduating in 2017. Marshall Baughman has also earned several additional certifications. Marshall completed "Introduction to Data Engineering" and "SQL for Data Science" courses from Coursera in August 2022. In addition, they have a certification in "Rudimentary Dari (Afghan Persian) Language" from the Defense Language Institute, although the specific month and year of obtaining this certification are not provided.
Concert Genetics
Genetic testing is the lynchpin of precision medicine, but the rapid pace of change in the market makes it enormously complex. Today, there are more than 75,000 unique genetic testing products on the market, and an average of 10 new products are added each day. This growth confounds the processes through which tests are ordered, resulted, billed and reimbursed. Founded in 2010 with a vision to simplify this complexity, Concert Genetics (formerly NextGxDx, Inc.) launched as a healthcare technology company dedicated to streamlining the genetic test selection, ordering, payment and management for clinicians, hospitals, laboratories and health plans. With a leading team of clinicians, researchers, data scientists and software engineers, Concert Genetics launched its proprietary solutions to enable end-to-end genetic testing management, from searching and comparing testing products, to tracking orders and results, to payment integrity and forecasting trends in pricing and utilization. Today, stakeholders across the healthcare system turn to Concert Genetics to better understand and navigate the rapid transformation to precision medicine that is underway.